Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth

Por Li, Qiang, O'Malley, Mark E, Bartlett, David L, Guo, Z Sheng
Publicado em 2011

Inhibitors of C5 Complement Enhance Vaccinia Virus Oncolysis

Por Magge, Deepa, Guo, Z. Sheng, O'Malley, Mark E., Francis, Lily, Ravindranathan, Roshni, Bartlett, David L.
Publicado em 2013

The Combination of Immunosuppression and Carrier Cells Significantly Enhances the Efficacy of Oncolytic Poxvirus in the Pre-Immunized Host

Por Guo, Z. Sheng, Parimi, Vamsi, O'Malley, Mark E., Thirunavukarasu, Pragatheeshwar, Sathaiah, Magesh, Austin, Frances, Bartlett, David L.
Publicado em 2010

Chronic Anti-inflammatory Drug Therapy Inhibits Gel-Forming Mucin Production in a Murine Xenograft Model of Human Pseudomyxoma Peritonei

Por Choudry, Haroon Asif, Mavanur, Arun, O’Malley, Mark E., Zeh, Herbert J., Guo, Z. Sheng, Bartlett, David L.
Publicado em 2012

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer

Por Sathaiah, Magesh, Thirunavukkarasu, Pragatheeshwar, O’Malley, Mark E., Kavanagh, Maihgan A., Ravindranathan, Roshni, Austin, Frances, Guo, Z. Sheng, Bartlett, David L.
Publicado em 2011

Herpes Simplex Virus Type 1 Vector-Mediated Expression of Nerve Growth Factor Protects Dorsal Root Ganglion Neurons from Peroxide Toxicity

Por Goins, William F., Lee, Kevin A., Cavalcoli, James D., O’Malley, Mark E., DeKosky, Steven T., Fink, David J., Glorioso, Joseph C.
Publicado em 1999

Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer

Por Downs-Canner, Stephanie, Magge, Deepa, Ravindranathan, Roshni, O’Malley, Mark E., Francis, Lily, Liu, Zuqiang, Guo, Z. Sheng, Obermajer, Natasa, Bartlett, David L.
Publicado no Ann Surg Oncol (2015)

A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis

Por Thirunavukarasu, Pragatheeshwar, Sathaiah, Magesh, Gorry, Michael C, O'Malley, Mark E, Ravindranathan, Roshni, Austin, Frances, Thorne, Steven H, Guo, Zong Sheng, Bartlett, David L
Publicado em 2013

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer

Por Ziauddin, Mohammed F, Guo, Z. Sheng, O'Malley, Mark E., Austin, Frances, Popovic, Petar J., Kavanagh, Maihgan A., Li, Jun, Sathaiah, Magesh, Thirunavukkarasu, Prag, Fang, Bingliang, Lee, Yong J., Bartlett, David L.
Publicado em 2010

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers

Por Downs-Canner, Stephanie, Guo, Zong Sheng, Ravindranathan, Roshni, Breitbach, Caroline J, O'Malley, Mark E, Jones, Heather L, Moon, Anne, McCart, Judith Andrea, Shuai, Yongli, Zeh, Herbert J, Bartlett, David L
Publicado no Mol Ther (2016)

Oncolytic Virotherapy for Ovarian Carcinomatosis Using a Replication-Selective Vaccinia Virus Armed with a Yeast Cytosine Deaminase Gene

Por Chalikonda, Sricharan, Kivlen, Maryann H., O’Malley, Mark E., Dong, Xiang Da (Eric), McCart, J. Andrea, Gorry, Michael C., Yin, Xiao-Yu, Brown, Charles K., Zeh, Herbert J., Guo, Z. Sheng, Bartlett, David L.
Publicado em 2007

First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity

Por Zeh, Herbert J, Downs-Canner, Stephanie, McCart, J Andrea, Guo, Zong Sheng, Rao, Uma N M, Ramalingam, Lekshmi, Thorne, Stephen H, Jones, Heather L, Kalinski, Pawel, Wieckowski, Eva, O'Malley, Mark E, Daneshmand, Manijeh, Hu, Kang, Bell, John C, Hwang, Tae-Ho, Moon, Anne, Breitbach, Caroline J, Kirn, David H, Bartlett, David L
Publicado no Mol Ther (2015)